Australia: first country to approve Bravecto Quantum
MSD Animal Health has announced the Australian Pesticides and Veterinary Medicines Authority (APVMA) has approved a novel injectable form of Bravecto (fluralaner) for the control of Ixodes holocyclus (paralysis tick) for 12 months, the treatment and prevention of Ctenocephalides felis (flea) infestations for 12 months, the control of Rhipicephalus sanguineus (brown dog tick) for 11 […]
Continue Reading